377 related articles for article (PubMed ID: 19106228)
61. Chromium supplementation enhances insulin signalling in skeletal muscle of obese KK/HlJ diabetic mice.
Chen WY; Chen CJ; Liu CH; Mao FC
Diabetes Obes Metab; 2009 Apr; 11(4):293-303. PubMed ID: 18721257
[TBL] [Abstract][Full Text] [Related]
62. Diabetes in Zucker diabetic fatty rat.
Shiota M; Printz RL
Methods Mol Biol; 2012; 933():103-23. PubMed ID: 22893404
[TBL] [Abstract][Full Text] [Related]
63. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
[TBL] [Abstract][Full Text] [Related]
64. Normalizing action of exendin-4 and GLP-1 in the glucose metabolism of extrapancreatic tissues in insulin-resistant and type 2 diabetic states.
Moreno P; Nuche-Berenguer B; Gutiérrez-Rojas I; Acitores A; Sancho V; Valverde I; González N; Villanueva-Peñacarrillo ML
J Mol Endocrinol; 2012 Feb; 48(1):37-47. PubMed ID: 22065862
[TBL] [Abstract][Full Text] [Related]
65. HIV-protease inhibitors induce expression of suppressor of cytokine signaling-1 in insulin-sensitive tissues and promote insulin resistance and type 2 diabetes mellitus.
Carper MJ; Cade WT; Cam M; Zhang S; Shalev A; Yarasheski KE; Ramanadham S
Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E558-67. PubMed ID: 18171911
[TBL] [Abstract][Full Text] [Related]
66. Interactions of the advanced glycation end product inhibitor pyridoxamine and the antioxidant alpha-lipoic acid on insulin resistance in the obese Zucker rat.
Muellenbach EA; Diehl CJ; Teachey MK; Lindborg KA; Archuleta TL; Harrell NB; Andersen G; Somoza V; Hasselwander O; Matuschek M; Henriksen EJ
Metabolism; 2008 Oct; 57(10):1465-72. PubMed ID: 18803954
[TBL] [Abstract][Full Text] [Related]
67. Soy β-conglycinin improves glucose uptake in skeletal muscle and ameliorates hepatic insulin resistance in Goto-Kakizaki rats.
Tachibana N; Yamashita Y; Nagata M; Wanezaki S; Ashida H; Horio F; Kohno M
Nutr Res; 2014 Feb; 34(2):160-7. PubMed ID: 24461318
[TBL] [Abstract][Full Text] [Related]
68. Melatonin improves glucose homeostasis in young Zucker diabetic fatty rats.
Agil A; Rosado I; Ruiz R; Figueroa A; Zen N; Fernández-Vázquez G
J Pineal Res; 2012 Mar; 52(2):203-10. PubMed ID: 21883445
[TBL] [Abstract][Full Text] [Related]
69. Activation of retinoid receptor-mediated signaling ameliorates diabetes-induced cardiac dysfunction in Zucker diabetic rats.
Guleria RS; Singh AB; Nizamutdinova IT; Souslova T; Mohammad AA; Kendall JA; Baker KM; Pan J
J Mol Cell Cardiol; 2013 Apr; 57():106-18. PubMed ID: 23395853
[TBL] [Abstract][Full Text] [Related]
70. Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis.
Kim JY; Park KJ; Hwang JY; Kim GH; Lee D; Lee YJ; Song EH; Yoo MG; Kim BJ; Suh YH; Roh GS; Gao B; Kim W; Kim WH
J Hepatol; 2017 Aug; 67(2):349-359. PubMed ID: 28365312
[TBL] [Abstract][Full Text] [Related]
71. Metformin and exercise reduce muscle FAT/CD36 and lipid accumulation and blunt the progression of high-fat diet-induced hyperglycemia.
Smith AC; Mullen KL; Junkin KA; Nickerson J; Chabowski A; Bonen A; Dyck DJ
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E172-81. PubMed ID: 17374701
[TBL] [Abstract][Full Text] [Related]
72. Azadirachta indica inhibits key enzyme linked to type 2 diabetes in vitro, abates oxidative hepatic injury and enhances muscle glucose uptake ex vivo.
Sanni O; Erukainure OL; Chukwuma CI; Koorbanally NA; Ibeji CU; Islam MS
Biomed Pharmacother; 2019 Jan; 109():734-743. PubMed ID: 30551526
[TBL] [Abstract][Full Text] [Related]
73. In vitro and in vivo hypoglycemia effect of oxyberberine, a novel HO-1 agonist: A renewed evidence linking HO-1 to diabetes mellitus.
Dou Y; Ai G; Huang R; Huang Z; Li Y; Liu Y; Xie J; Chen J; Su Z
Phytomedicine; 2022 Jul; 101():154135. PubMed ID: 35509133
[TBL] [Abstract][Full Text] [Related]
74. Activation of PPARgamma enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats.
Golfman LS; Wilson CR; Sharma S; Burgmaier M; Young ME; Guthrie PH; Van Arsdall M; Adrogue JV; Brown KK; Taegtmeyer H
Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E328-36. PubMed ID: 15797988
[TBL] [Abstract][Full Text] [Related]
75. Gallic acid attenuates high-fat diet fed-streptozotocin-induced insulin resistance via partial agonism of PPARγ in experimental type 2 diabetic rats and enhances glucose uptake through translocation and activation of GLUT4 in PI3K/p-Akt signaling pathway.
Gandhi GR; Jothi G; Antony PJ; Balakrishna K; Paulraj MG; Ignacimuthu S; Stalin A; Al-Dhabi NA
Eur J Pharmacol; 2014 Dec; 745():201-16. PubMed ID: 25445038
[TBL] [Abstract][Full Text] [Related]
76. Increased oxidative stress and mitochondrial dysfunction in zucker diabetic rat liver and brain.
Raza H; John A; Howarth FC
Cell Physiol Biochem; 2015; 35(3):1241-51. PubMed ID: 25766534
[TBL] [Abstract][Full Text] [Related]
77. Mechanism of insulin resistance in a rat model of kidney disease and the risk of developing type 2 diabetes.
Dion F; Dumayne C; Henley N; Beauchemin S; Arias EB; Leblond FA; Lesage S; Lefrançois S; Cartee GD; Pichette V
PLoS One; 2017; 12(5):e0176650. PubMed ID: 28459862
[TBL] [Abstract][Full Text] [Related]
78. [Effects of early insulin therapy on nuclear factor kappaB pathway in skeletal muscle of diabetes: experiment with rats].
Bi Y; Sun WP; Chen X; Cai MY; Liang H; Zhu YH; He XY; Yu QQ; Li M; Weng JP
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(46):3287-92. PubMed ID: 19159557
[TBL] [Abstract][Full Text] [Related]
79. Hyperglycemia contributes insulin resistance in hepatic and adipose tissue but not skeletal muscle of ZDF rats.
Nawano M; Oku A; Ueta K; Umebayashi I; Ishirahara T; Arakawa K; Saito A; Anai M; Kikuchi M; Asano T
Am J Physiol Endocrinol Metab; 2000 Mar; 278(3):E535-43. PubMed ID: 10710509
[TBL] [Abstract][Full Text] [Related]
80. Correcting Postprandial Hyperglycemia in Zucker Diabetic Fatty Rats With an SGLT2 Inhibitor Restores Glucose Effectiveness in the Liver and Reduces Insulin Resistance in Skeletal Muscle.
O'Brien TP; Jenkins EC; Estes SK; Castaneda AV; Ueta K; Farmer TD; Puglisi AE; Swift LL; Printz RL; Shiota M
Diabetes; 2017 May; 66(5):1172-1184. PubMed ID: 28246292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
